Skip to main content
Fig. 5 | Stem Cell Research & Therapy

Fig. 5

From: Autologous mesenchymal stem cells or meniscal cells: what is the best cell source for regenerative meniscus treatment in an early osteoarthritis situation?

Fig. 5

Comparison of collagen II (Col2) ELISA results of aggregates from human meniscal cells (black) (three pellets at each time point of each patient (n = 14)) and mesenchymal stem cells (MSCs; gray) (three pellets at each time point of each patient (n = 6)) after 21 days of culture in chondrogenic media. Meniscal cells from non-refixable meniscal tears show no chondrogenic potential. *P < 0.005

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512